Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs.
Ontology highlight
ABSTRACT: Amyloid-β peptides, through highly sophisticated enzymatic machinery, are universally produced and released in an action potential synchronized manner into the interstitial fluids in the brain. Yet no native functions are attributed to amyloid-β. The amyloid-β hypothesis ascribes just neurotoxicity properties through build-up of soluble homomeric amyloid-β oligomers or fibrillar deposits. Apolipoprotein-ε4 (APOE4) allele is the only confirmed genetic risk factor of sporadic Alzheimer's disease; once more it is unclear how it increases the risk of Alzheimer's disease. Similarly, central cholinergic signalling is affected selectively and early in the Alzheimer's disease brain, again why cholinergic neurons show this sensitivity is still unclear. However, the three main known Alzheimer's dise
SUBMITTER: Kumar R
PROVIDER: S-EPMC4949388 | biostudies-literature | 2016 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA